Approaches for preventing healthcare-associated infections: Go long or go wide?

Infection Control and Hospital Epidemiology

Volumn 35, Issue 7, 2014, Pages 797-801

  Septimus, Edward ^a,b   Weinstein, Robert A ^c   Perl, Trish M ^d   Goldmann, Donald A ^e,f   Yokoe, Deborah S ^g  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Clinical Service Group Hospital Corporation of America   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUTE FOR HEALTHCARE IMPROVEMENT   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CEFOTAXIME; CHLORHEXIDINE GLUCONATE; POLYMYXIN; PSEUDOMONIC ACID; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EMERGENCY CARE; HAND WASHING; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; NONHUMAN; NOTE; RESPIRATORY TRACT INFECTION; SURGICAL GLOVE; SURGICAL GOWN; CROSS INFECTION; PREVENTION AND CONTROL; PROCEDURES; ACTIVE SURVEILLANCE TESTING; BACTEREMIA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLOSTRIDIUM DIFFICILE INFECTION; HEALTH CARE PERSONNEL; HEALTH SURVEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROTECTIVE CLOTHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); STAPHYLOCOCCUS INFECTION; UNIVERSAL GLOVING; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFECTION CONTROL;

EID: 84902974228     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676535     Document Type: Note

References (38)

1. Marschall J, Mermel LA, Fakih M, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35(7): 753-771 (in this issue).
2. Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35(7):772-796 (in this issue).
3. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010;14(suppl 4):S3-S5.
4. Morgan DJ, Pineless LL, Shardell M, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol 2013;34(1):69-73.
5. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009;37(2):85-93.
6. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003;290(14):1899-1905.
7. Vos MC, Behrendt MD, Melles DC, et al. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009;30(10): 977-984.
8. Jain R, Kralovic SM, Evans ME, et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-1430.
9. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011;364:1407-1418.
10. Glick SB, Samson DJ, Huang E, et al. Screening for methicillinresistant Staphylococcus aureus (MRSA). Comparative Effectiveness Review no. 102. AHRQ Publication no. 13-EHC043-EF. Rockville, MD: Agency for Healthcare Research and Quality; June 2013. http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
11. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem- resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620-626.
12. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29:966-968.
13. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenemase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30:447-452.
14. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31:341-347.
15. Palmore TN, Henderson DK. Managing transmission of carbapenem- resistant Enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis 2013;57:1593-1599.
16. Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis 2014;58:697-703.
17. Centers for Disease Control and Prevention. CRE toolkit: guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2012. http://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Accessed March 13, 2014.
18. Erasmus V, Daha TJ, Brug H, et al. Systematic review of studies on compliance with hand hygiene. Infect Control Hosp Epidemiol 2010;31:283-294.
19. Jarlier V, Trystram D, Brun-Buisson C, et al. Curbing methicillin- resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010;170:552-559.
20. Tenorio AR, Badri SM, Sahgal NB, et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin resistant enterococcus species by health care workers after patient care. Clin Infect Dis 2001;32:826-829.
21. Yin J, Schweizer ML, Herwaldt LA, et al. Benefits of universal gloving on hospital-acquired infections in acute care pediatric units. Pediatrics 2013;131:e1515-e1520.
22. Harris AD, Pineless L, Belton B, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 2013;310(15):1571-1580.
23. Vernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of van- comycin-resistant enterococci. Arch Intern Med 2006;166:306-312.
24. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533-542.
25. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099-1106.
26. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368:2255-2265.
27. Derde LPG, Cooper BS, Goossens H, et al, on behalf of the MOSAR WP3 Study Team. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014;(14):31-39.
28. Munoz-Price LS, De La Cuesta C, Adams S, et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010;31:1074-1077.
29. D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E, Liberati A. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009;(4):CD000022. doi:10.1002/14651858.CD000022.pub3.
30. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007; 45(suppl 2):S112-S121.
31. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24(9):699-706.
32. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166: 1945.
33. Datta R, Platt R, Yokoe DS, et al. Environmental cleaning interventions and risk of acquiring multidrug resistant organisms from prior room occupants. Arch Intern Med 2011;171(6):491-494.
34. Shaughnessy MK, Micielli RL, DePestel D, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32:201-206.
35. Nseir S, Blazejewski C, Lubret R, et al. Risk of acquiring multidrug- resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Micro Infect 2011;17:1201-1208.
36. Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006;42(11):1552-1560.
37. Sandora TJ, Goldmann DA. Preventing lethal hospital outbreaks of antibiotic-resistant bacteria. N Engl J Med 2012;367:2168-2170.
38. Langley GL, Nolan KM, Nolan TW, Norman CL, Provost LP. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. 2nd ed. San Francisco: Jossey-Bass, 2009.